BBM-C101

N/A

Report date: 2025/11/27 10:58:36

Base Information

Drug NameBBM-C101
Drug Alias NameE6/E7 gene therapy (Belief BioMed)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionProtein E7 modulatorsProtein E6 modulatorsMacrophage colony stimulating factor 2 modulators
TargetsProtein E7Protein E6Macrophage colony stimulating factor 2
Therapy Area/IndicationsSquamous Intraepithelial Lesions of the Cervix
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBelief BioMed Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Mianyi Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSquamous Intraepithelial Lesions of the Cervix
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A